Danish food company Chr. Hansen has signed a conditional deal to buy Sweden-based Arla Foods' subsidiary Medipharm to boost its growth in the probiotic segment. "The agreement further substantiates our strategic focus on developing new and exciting applications with probiotic cultures within the animal health as well as human health areas," Chr. Hansen CEO Lars Frederiksen said. The acquisition is expected to be completed next year.
Published in Brief: